Cy­to­ki­net­ic­s' PhI­II car­diomy­opa­thy win sets up show­down with Bris­tol My­ers and sparks M&A spec­u­la­tion

Cy­to­ki­net­ics’ ex­per­i­men­tal med­i­cine for a ge­net­ic heart con­di­tion known as hy­per­trophic car­diomy­opa­thy helped pa­tients do sig­nif­i­cant­ly bet­ter on an ex­er­cise test that’s used to mea­sure …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER